YOKNEAM, Israel, Oct. 9, 2025 /PRNewswire/ -- InMode Ltd. (INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the ...

Inmode ( (INMD)) has released its Q3 earnings. Here is a breakdown of the information Inmode presented to its investors. InMode Ltd. is a global provider of innovative medical technologies, ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...

The latest update is out from InMode ( (INMD)). On November 5, 2025, InMode Ltd. announced its financial results for the third quarter of 2025, reporting revenues of $93.2 million, a decrease from ...

Gross margins decline — Yair Malca stated, "GAAP and non-GAAP gross margins in Q3 were 78%, down from 82% reported in Q3 2024," citing the anticipated impact of tariffs as a direct driver. Reduced ...

InMode Ltd. remains a global leader in minimally invasive aesthetic medical devices, trading at a deep discount with a net cash position covering 58% of market cap. Despite a sharp 85% drawdown since ...

YOKNEAM, Israel (AP) — YOKNEAM, Israel (AP) — InMode Ltd. (INMD) on Wednesday reported net income of $21.9 million in its third quarter. The Yokneam, Israel-based company said it had net income of 34 ...

To the Board Members of InMode: InMode's valuation has continued to contract. We believe this is partly due to management's chaotic leadership; one reason sales remain low is the detrimental decision ...

IRVINE, Calif., Nov. 3, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has appointed Michael Dennison, most recently Vice President of ...